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Background: Multiple growth factors are known to control several aspects of neuronal biology, consecutively
acting as morphogens to diversify neuronal fates, as guidance cues for axonal growth, and as modulators of
survival or death to regulate neuronal numbers. The multiplicity of neuronal types is permitted by the
combinatorial usage of growth factor receptors, each of which is expressed in distinct and overlapping subsets of
neurons, and by the multitasking role of growth factor receptors, which recruit multiple signalling cascades
differentially required for distinct biological outcomes. We have explored signalling robustness in cells where a
given receptor tyrosine kinase (RTK) elicits qualitatively distinct outcomes. As the HGF/Met system regulates several
biological responses in motor neurons (MN) during neuromuscular development, we have investigated the
signalling modalities through which the HGF/Met system impacts on MN biology, and the degree of robustness of
each of these functions, when challenged with substitutions of signalling pathways.
Results: Using a set of mouse lines carrying signalling mutations that change the Met phosphotyrosine binding
preferences, we have asked whether distinct functions of Met in several MN subtypes require specific signalling
pathways, and to which extent signalling plasticity allows a pleiotropic system to exert distinct developmental
outcomes. The differential ability of signalling mutants to promote muscle migration versus axonal growth allowed
us to uncouple an indirect effect of HGF/Met signalling on nerve growth through the regulation of muscle size
from a direct regulation of motor growth via the PI3 kinase (PI3K), but not Src kinase, pathway. Furthermore, we
found that HGF/Met-triggered expansion of Pea3 expression domain in the spinal cord can be accomplished
through several alternative signalling cascades, differentially sensitive to the Pea3 dosage. Finally, we show that the
regulation of MN survival by HGF/Met can equally be achieved in vitro and in vivo by alternative signalling cascades
involving either PI3K-Akt or Src and Mek pathways.
Conclusions: Our findings distinguish MN survival and fate specification, as RTK-triggered responses allowing
substitutions of the downstream signalling routes, from nerve growth patterning, which depends on a selective,
non-substitutable pathway.
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The assembly of locomotor circuits relies on the parallel
development of spinal motor neurons (MNs) and their
target muscles, and subsequently, on their coordinated
functional wiring. This involves the stepwise acquisition
of cell diversification programs in both cell types, each
of which leads to the generation of distinct subtypes, the
subsequent matching of each motor pool with its cog-
nate target muscle through topographical arrangement
of their axonal projections, and finally a process that al-
lows numerical matching of MN pool size to the size of
the target muscle [1,2]. During these consecutive phases,
a number of aspects of MN biology, including specifica-
tion, axon growth, guidance and survival, are controlled
by multiple target-derived growth factors and their
receptors [1]. Most of these growth factors are capable
of eliciting multiple responses and the specialisation ap-
pears to involve the subtype-specific distribution of their
cognate receptors, respectively established through the
combinatorial distribution of fate-specifying transcrip-
tion factors [3]. The resulting combinations of growth
factor receptors define a unique set of growth factor
responses for each MN subtype, matching either specific
muscles or a functional subtype [4,5].
An additional level of complexity appears when consid-
ering signalling modalities. The actions of each growth
factor receptor upon ligand binding involve the activation
of cytoplasmic signalling pathways [6]. The discovery by
Tony Pawson of conserved domains in signalling mole-
cules conferring binding ability to activated receptor tyro-
sine kinases (RTKs) has revolutionised how we see that
RTK signalling regulates cellular behaviours. In particular,
a profusion of cytoplasmic signalling effectors, binding
phosphorylated tyrosines via Src homology domain type 2
(SH2) and type 3 (SH3) and phosphotyrosine binding
domain (PTB), can be recruited upon receptor activa-
tion by their ligands, to mediate multiple, qualitatively
different, biological responses to a given factor. One sig-
nalling adaptor can be used as an effector of different bio-
logical responses to distinct growth factors. Conversely, a
given growth factor receptor can employ distinct signalling
effector pathways to mediate distinct cellular responses.
Introducing point mutations in the genomic loci of RTKs,
such as TrkC, TrkB, Met, Pdgfr or Ret, by selectively modi-
fying the binding sites through which they recruit cyto-
plasmic effectors, has been instrumental in distinguishing
the respective contribution of signalling adaptors, such
as PLCγ, Shc, Grb2, PI3K and Src, in mediating quali-
tatively distinct cellular responses in vivo [7-12]. The
studies cited above compared cellular behaviours (such as
survival, migration, proliferation and target innervation)
adopted by cell types with very different biological histor-
ies (i.e. neurons versus muscles or vascular smooth muscle
cells) but did not distinguish distinct subtypes (molecularor anatomical) within a generic cell type. However, RTK
signalling requirements for a given biological response
might not always be identical in different cell types or sub-
types. Signalling requirements may be determined by the
intrinsic competence of each cell type to provide a robust
signal transduction platform capable of executing the
function, such competence being directly linked to the
intrinsic molecular identity of the cell. Thus, to define the
robustness of a specific biological outcome requires un-
derstanding for a cell type the degree to which several al-
ternative signalling pathways can substitute for each other
to execute qualitatively distinct RTK-driven responses,
and distinguishing permissive from non-permissive path-
ways. We chose to address this issue by modulating the
signalling competences of a growth factor/RTK system in
charge of multiple biological functions in one unique cell
type, focusing on MNs, and by exploring specificity versus
plasticity of the pathways that intercalate to execute each
of these biological responses.
Among the plethora of factors known to influence MN
biology, we chose to focus on hepatocyte growth factor
(HGF), a multifunctional growth factor whose functions
are mediated by the Met RTK. HGF influences MN biol-
ogy by acting both on MNs and on muscles. Produced by
the limb bud mesenchyme, HGF first acts on muscle mi-
gration by triggering the delamination of myoblast precur-
sors from limb level somites [13]. This event is necessary
for myoblasts to undergo their long-range migration to-
wards the limbs [13-15]. In embryos lacking Met signal-
ling, the absence of limb muscles causes the death of all
limb MNs [4,16], most likely by depleting all muscle-
derived neurotrophic factors required to support MN sur-
vival. Besides this indirect influence, HGF/Met signalling
also plays a number of direct functions in MNs, including
regulating motor axon growth [4,9,17,18], MN subtype
specification [4,16] and MN survival [4,18,19].
Using tissue-specific ablation of the Met receptor, we
have recently shown that as development proceeds, HGF
acts on distinct MN pools, in which it successively con-
trols several specific biological pathways [4]. On a subset
of Met-expressing brachial MNs, HGF acts at early
stages (during a muscle-independent period), by influen-
cing cell fate specification (through cell autonomous in-
duction of expression of the transcription factor Runx1
and non-cell autonomous induction of the transcription
factor Pea3 in neighbouring neurons) and consequently
axon growth toward and within their target muscle
(cutaneous maximus (CM)) [4,9,16]. After the onset
of muscle-dependency for MN survival, highlighted by a
peak of naturally occurring cell death (NOCD), which
spreads among motor columns to eliminate supernumer-
ary MNs [20], we recently discovered a switch in both the
biological response and in the MN pools supported by
HGF/Met. As shown with neural-specific ablation of Met
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survival of a distinct pool of Met-expressing MNs that
innervate the pectoralis minor muscle, whereas it is no
longer required to support CM MNs [4]. Thus, the bio-
logical response to a given target-derived growth factor
depends both on the MN subtype and on timing, offering
an interesting context in which to address robustness
versus specificity of signalling requirements.
In this study, we took advantage of an allelic series of
met, including: a) the metd signalling dead allele [15];
b) the hypomorphic met2P and met2S signalling mutant
alleles, in which the multifunctional docking site is con-
verted into optimal binding sites for phosphatidylinositol
3-kinase (PI3K) or Src, respectively [9]; c) an alternative
knockout/knock-in metLacZ allele [4] and d) a conditional
metFlox allele [4,21]. We asked whether execution of three
different biological responses (axonal patterning, specifi-
cation and survival) elicited by the pleiotropic RTK
Met in distinct MN subtypes, is compatible with sub-
stitutions of the signalling pathways, or requires selective
non-substitutable signalling routes. By uncoupling Met
functions in MNs from its function in muscle migration,
and by selectively allowing Met to signal through either
Src or PI3K optimal binding sites, we found that: 1) while
HGF/Met signalling indirectly impacts on nerve growth
through the regulation of muscle size in the limbs, a direct
regulation of motor growth is achieved in the presence of
limiting amounts of muscles by activating PI3K, but not
Src, pathway; 2) the non-cell autonomous function of
HGF/Met that allows expansion of the Pea3 expression
domain in the spinal cord [16], can be accomplished
through several alternative signalling cascades, although
their competence is differentially sensitive to Pea3 dosage;
3) regulation of MN survival by HGF/Met can be equally
achieved in vitro and in vivo by alternative signalling cas-
cades involving either PI3K-Akt or Src and Mek pathways.
Results
Most signalling by the Met receptor is mediated by two
C-terminal tyrosines, referred to as multifunctional dock-
ing sites. The surrounding amino-acid environment
(Y1349VHVNATY1356VNV) is permissive to the binding of
multiple signalling adaptors (Figure 1A) [22]. Whereas
converting both tyrosines to phenylalanine completely
abrogates signal transduction (Metd signalling dead re-
ceptor [15]), modifying the amino-acids surrounding these
tyrosines can alter the selective affinity for some cytoplas-
mic effectors (Figure 1A) [9]. By converting the two
docking sites into optimal binding sites for PI3K (Y1349/
1356MDMS) or for Src (Y1349/1356EEI), the Met
2P and
Met2S receptors, respectively, were designed to determine
the impact of imposing the cytoplasmic effector through
which Met can signal, thus raising its contribution above
generic signalling levels (Figure 1A). These specificity-switch mutants have been instrumental in addressing the
relevance of selective pathways in several biological con-
texts [9,23-26]. Regarding the function of HGF/Met that
triggers myoblast delamination and migration towards
limb buds [13-15], the Met2P and Met2S specificity-switch
mutants have limited ability to elicit long-range myoblast
migration (Additional file 1: Figure S1A) [9]. In spite of
this, the small number of migrating myoblasts is never-
theless sufficient to account for the formation of a
substantial amount of muscle in both forelimbs and
hindlimbs (Additional file 1: Figure S1A and Figure 2B),
and does not affect MN numbers prior to the onset of
muscle dependency for survival (Figure 2: lumbar MNs;
Additional file 1: Figure S1B: brachial MNs) [16]. This
allelic series of met mutants thus represents an excellent
toolbox to uncouple the effects of loss of muscle from dir-
ect functions of Met in MNs. Here, we took advantage
of the differences in signalling competences of these two
versions of Met to determine the degree of flexibility
versus specificity for a given biological outcome, such
as those elicited by HGF/Met in selective subsets of
Met-dependent MN pools (Figure 1B).
Distinct signalling requirement for nerve patterning
HGF, initially provided by the limb mesenchyme and later
by the muscles themselves [19,27,28], is known to pro-
mote growth, to exert chemoattractant activity [17,18] and
to pattern nerve branching of motor axons [12,17,18].
However, a number of abnormalities in peripheral nerve
patterns observed in met or hgf loss-of-function mutants
[12,17,18], result from secondary effects of the absence of
muscles, from the subsequent depletion of muscle-derived
guidance signals and from early changes in MN specifica-
tion [16]. Thus, in spite of extensive documentation of
constitutive knockout phenotypes [9,17,18] and our own
conditional studies bypassing requirements prior to
NOCD [4], formal in vivo demonstration of a direct re-
quirement for Met in axon growth and path-finding is still
currently lacking. We have previously shown that neural-
specific Met excision with a Nestin-cre driver was only
complete by the end of the NOCD period [4], preventing
use from addressing the possibility of a direct requirement
for axon growth and guidance prior to NOCD using a
conditional approach. Thus, our paradigm using the
specificity-switch mutants is suitable for addressing this
question.
We previously reported that HGF/Met signalling influ-
enced axon growth in the CM muscle [9]. However,
guidance of CM MN axons to their target does not
reflect a direct function of HGF/Met in axon growth, as
it is conditioned by an early specification program estab-
lishing Pea3 expression domain in a MN pool, which is
under the control of Met as well (see later). To circum-
vent these caveats and examine signalling modalities of
Figure 1 Using Met specificity-switch mutants to study plasticity of HGF/Met functions in motor neurons. (A) The wild type (WT) and
three signalling mutant versions of the Met receptors used in this study. The WT receptor (MetWT) conveys intracellular signalling mainly through
two tyrosine residues located in the C-terminal tail. Upon HGF binding and phosphorylation by the Met kinase domain, these tyrosines recruit
several cytoplasmic signalling effectors, including Gab1, PI3K, Src, Grb2 and a number of others. The specificity-switch mutants Met2P and Met2S
have been designed to carry optimal binding sites for PI3K and Src, so as to favour their respective recruitment/activation [9]. The Metd receptor
has its two tyrosines replaced by phenylalanines and is thus signalling incompetent [9,15]. As a consequence, metd/d embryos have phenotypes
indistinguishable from null mutants. (B) Time course of developmental events regulated by HGF/Met signalling that influence MN biology,
summarising our earlier findings [4,16]. The period shown is divided into an early period, from E10.5 to E13.5, before synaptic contact between
MNs and muscles, and a late period, during which MNs are dependent on muscle-derived trophic factors for their survival. The transition between
the two periods is marked by a pronounced peak of MN death (NOCD), indicating numerical adjustment of MN numbers to target muscle size.
During the muscle-independent period, before NOCD, HGF/Met signalling controls migration of limb myoblasts, axon growth of a subset of
Met-expressing MNs, cell autonomous induction of runx1 [4] and non-cell autonomous propagation of Pea3-expression [16]. After NOCD, HGF/
Met controls the survival of a distinct pool of MNs, innervating the pectoralis minor muscle, while it is no longer required for trophic support of
CM or latissimus dorsi (LD) MN pools.
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Figure 2 Met signalling is required for hindlimb nerve patterning prior to the onset of muscle-dependency for MN survival. (A) Lumbar
spinal nerves and plexuses at hindlimb levels based on a lateral view of an E11.5 WT embryo. The sciatic plexus (from which the tibial (ventral)
and peroneal (dorsal) nerves emerge) receives axons mostly from L4 and L5 spinal segments, while the femoral plexus (anterior) collects axons
mostly from L2 and L3 spinal segments. (B) ISH with Met and Ret probes on E12.5 WT spinal cords. The LMC pool corresponding to peroneal
MNs is indicated in yellow, spanning from mid L3 to L6. (C) Met expression was followed by Salmon-Gal staining in spinal cords from E12.5
metLacZ/+, metLacZ/d, metLacZ/2P, and metLacZ/2P embryos. The position of peroneal MNs is indicated in yellow. (D) Quantification of the size of
Met-expressing MN pools along the orange line at L5 level. Each plot represents the average signal distribution of the indicated number of spinal
cord sides (metLacZ/+: n=24; metLacZ/d: n=12; metLacZ/2P: n=8; metLacZ/2P: n=10. (E) Ret expression was followed by ISH in lumbar spinal cords from
E12.5 WT, metd/d, met2P/2P, met2S/2S embryos. (F) The size of the Ret-expressing MN pools was quantified along the orange line at L5 level. Each
plot represents the average signal distribution of the indicated number of spinal cord sides (met+/+: n=12; metd/d: n=10; met2P/2P: n=8; met2S/2P:
n=6). (G,H) Quantifications and statistical analyses of the sum of signal intensity corresponding to measurements of metLacZ expression (G) or Ret
ISH staining (H) based on intensity plots in (D) and (F), respectively. The numbers of samples are as indicated in (D) and (F). At E12.5 the size of
the MN population is not significantly altered by the reduced muscle mass in metd/d, met2P/2P, and met2S/2P embryos, indicating that this stage
precedes the phase of MN death.
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axonal growth and guidance, we chose to investigate the
motor nerve pattern in the dorsal hindlimb. While Met
expression in brachial spinal cord segments is restricted
to the Pea3-expressing MN pool, in which HGF/Met
controls cell fate specification, Met is also expressed in
pools of lumbar MNs, including medial and lateral LMC
MN columns at sciatic levels L4 to L6, in which Pea3 is
not co-expressed (Figure 2A,B) [19]. We first established
that at E12.5, prior to the onset of cell death caused by
trophic deprivation, no difference in the amount of Ret-
expressing MNs in the lumbar segments could be detected
in any of the met mutant genotypes (metd/d, met2P/2P and
met2S/2S) compared to controls (Figure 2E,F,H). Further
confirmation came from analysis of met-expressing
neurons directly, by following one copy of the metLacZ
reporter/knockout allele, in metLacZ/+, metLacZ/d, metLacZ/2P
and metLacZ/2S embryos (Figure 2C,D,G).
We next performed careful correlative analysis of
nerve and muscle patterns in the dorsal hindlimb, using
whole-mount anti-neurofilament staining and MyoD in
situ hybridisation (ISH). In WT embryos, the dorsal
shank is mainly innervated by the peroneal nerve branch
emerging from the sciatic plexus (Figure 2A) [29]. This
nerve follows a stereotyped trajectory, first crossing the
extensor digitorum longus (EDL) muscle on its proximal
extremity, and continuing its distal progression towards
the foot in the space between the EDL muscle and the
tibialis anterior (TA) muscle (see scheme in Figure 3D).
In wild-type (WT) embryos, the sharp turn made by the
peroneal nerve between the portion crossing the EDL
muscle and the longitudinal portion running between
EDL and TA muscles consistently defines an angle (α) of
approximately 120° on average. Furthermore, at the
contact site between the nerve and each muscle, a few
axonal side branches leave the nerve to enter the muscle
where they will later establish synapses with muscle
fibres (Figure 3D, blue arrows, see also Additional file 2:
Figure S2E). In metd/d embryos, in the absence of limbmuscles, the peroneal nerve displayed no detectable side
branches and a significantly altered shape (Figure 3A,C),
running straight through the limb with α increased to
approximately 160° on average (Figure 3E, **P < 0.001).
Although we found reduced amounts of Pea3-expressing
MNs in the lumbar region (Additional file 2: Figure S2C),
this peroneal nerve phenotype is not a consequence of
altered Pea3 expression, as: (a) Pea3 is not co-expressed
with met in peroneal MN pools at L4–L5 levels (yellow
dotted pools, Additional file 2: Figure S2B), and (b)
Pea3-null mutants exhibit an intact peroneal nerve shape
(Additional file 2: Figure S2D). Thus, the peroneal nerve
shape is an appropriate model for unambiguously estab-
lishing Met-signalling requirements for axonal growth,
without possible consequences related to defects in
muscle formation and/or MN specification.
We first established a cartography of developing mus-
cles in met2P/2P and met2S/2S dorsal hindlimbs and found
an asymmetric pattern, with the posterior muscles
(including peroneus longus and peroneus digiti) showing
a reduced mass but almost normal shape, while muscles
of the anterior group (including EDL and TA muscles)
were severely reduced in size, and the distal muscle mass
was completely absent (Figure 3B,C,G). The anterior-
most muscle, TA, was the most affected, and its range of
phenotypical variations included a complete absence in a
small subset of embryos. The overall quantification of its
size revealed no significant difference between met2P/2P
and met2S/2S embryos. There was also no significant differ-
ence in the size of the EDL until E14.5, when secondary
myogenesis starts [30]. While examining the nerve
pattern, we found that the peroneal nerve of met2P/2P em-
bryos had a shape similar to that of control embryos, with
an average α of approximately 135°, and its side branches
in contact with EDL and TA were present in most cases
(with an average number of eight side branches per nerve
compared to nine per nerve in controls; Figure 3F). In
contrast, the peroneal nerve shape of met2S/2S embryos
was identical to that seen in metd/d mutants, with an
Figure 3 (See legend on next page.)
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Figure 3 Uncoupling muscle-dependent from Met-dependent axonal branching. (A) Anti-neurofilament (NF) immunohistochemistry on
E12.5 and E13.5 hindlimbs of WT and met mutants. (B) MyoD ISH showing differentiating muscles in E13.5 and E14.5 hindlimbs. (C) Recapitulative
schemes positioning hindlimb muscles and nerves with respect to each other. Colour code for nerves; green: ventral nerves not in the focal plane
and unaffected by lack of Met signalling; red: peroneal nerve motor branches, innervating the dorsal limb compartment, corresponding to the
common peroneal nerve as it emerges from the sciatic plexus. The cutaneous sensory peroneal nerve branch is shown in blue. (D) Quantification
parameters. α: angle between the transverse and distal portion of the deep peroneal nerve. β: angle between common and deep peroneal nerve
portions, used as internal morphological landmark. Blue arrows: contact sites with ta and edl muscles where the number of peroneal nerve side
branches were quantified. (E) The nerve phenotype severity was assessment by measuring the α and β angles, in WT (n=12), metd/d (n=10),
met2P/2P (n=7), and met2S/2S (n=9) E12.5 and E13.5 hindlimbs. Each dot represents one embryo side. The same colours representing the genotypes
were used in all graphs. (F) Plot showing the respective numbers of side-branches per peroneal nerve (pooling ta and edl branches), in E13.5 WT
(n=6), metd/d (n=7), met2P/2P (n=6), and met2S/2S (n=8) hindlimbs. Differences between WT and metd/d embryos, and between met2P/2P and met2S/2S
embryos, respectively, are significant (Mann-Whitney test, p<0.01).) (G) Measurements of ta and edl muscle surface were performed on WT (n=6),
metd/d (n=6), met2P/2P (n=8), and met2S/2S (n=7) E13.5 and E14.5 hindlimbs stained with MyoD ISH. Areas were expressed as percentage of the
mean area in WT embyos (represented as 100%). The plot therefore shows only met2P/2P and met2S/2S values, each dot representing one
embryo side.
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towards EDL and TA never detected. Of notice, another
internal morphological landmark, β, reflecting the turn
made by the peroneal nerve emerging from the sciatic
nerve, did not exhibit significant differences between
metd/d, met2S/2S and met2P/2P embryos, although signifi-
cantly affected by the morphological changes in muscle
shape compared to controls. Altogether, these data dem-
onstrate that signalling by Met2P, but not by Met2S, can
efficiently promote side-branch formation, and shape the
peroneal nerve, provided that the corresponding muscle is
present in the limb (likely to supply either HGF itself or a
cofactor necessary for the growth response). Furthermore,
they indicate that distinct signalling cascades, such as
those triggered by these two receptor variants, are not
equivalent in their capacity to execute nerve pattern-
ing by Met.
Signalling cascades effective at mediating Met-triggered
Pea3-domain expansion are differentially sensitive to
Pea3 gene dosage
We next investigated the signalling requirement for cell
fate specification by focusing on the program that
defines which MN pools express the transcription factor
Pea3, in which HGF/Met signalling is required [16]. We
have previously shown that the Pea3-expressing MN
population at brachial levels is constituted of two main
subgroups of MNs [16]. In the first group of pioneer
MNs, Pea3 expression is initially induced by glial-derived
neurotrophic factor (GDNF), produced by the target
muscle [31]. HGF then acts on the same pioneer MNs, via
Met, instructing them to induce Pea3 expression in
additional neurons, a feed-forward induction process that
leads to lateral and anterior expansion of the Pea3 expres-
sion domain (summarised in Additional file 3: Figure S3,
see also [16,31]). Such biphasic establishment of the
Pea3 expression domain is illustrated by the phenotype
of metd/d mutants, in which this second process is abol-
ished, leaving only the GDNF-dependent population [16].Importantly, the size reduction of Pea3-expressing motor
pools observed in metd/d mutants occurred before the on-
set of muscle dependency and was not caused by muscle
depletion, since such a defect was not observed in Pax3-
deficient (Pax3Sp/Sp) embryos, which also lack limb mus-
cles [16]. Whole-mount ISH with Pea3 on E12.5 spinal
cords revealed the Pea3 expression domain in met2P/2P
and met2S/2S spinal cords had a normal shape, contrast-
ing with the reduced shape displayed in metd/d mutants
(Figure 4A,B,E). We ruled out that the competence of
Met2P and Met2S signalling mutants to mediate expansion
of Pea3 expression domain could be indirectly influenced
by the reduced muscle content, by showing that: (a) no
detectable changes in the amount of Ret-expressing MNs
were found in E12.5 metd/d, met2P/2P and met2S/2S brachial
spinal cords (Additional file 1: Figure S1B); (b) the Pea3
domain expansion is independent of muscle-derived
signals, and occurs at a stage when the muscle phenotype
of metd/d, met2P/2P and met2S/2S embryos is almost
equivalent (E11.5) (Additional file 1: Figure S1A; see also
[16]); (c) comparably sized Pea3 and Ret expression do-
mains (Additional file 4: Figure S4B,C and Figure 4B) were
also observed in the brachial spinal cord of met2Pneo/2Pneo
and met2Sneo/2Sneo signalling-switch mutant embryos still
carrying the neo cassette (which had served to engineer
the modified alleles, the latter causing attenuated ex-
pression levels of the mutant receptors [9] and result-
ing in further reduced muscle masses (Additional file 4:
Figure S4A)). Thus, the signalling routes used by the
Met2P and Met2S specificity-switch mutants are equally
sufficient, even when sensitised by lowered receptor
expression levels, to execute the mechanisms leading to
Pea3 propagation.
The signalling cascades triggered by the Met2P and
Met2S specificity-switch mutants involve distinct, non-
equivalent mechanisms [9]. However, besides the se-
lective activation of PI3K and Src pathways, the two
receptors also share a common set of signalling effectors,
such as the adaptor molecule Gab1 and its downstream
Figure 4 (See legend on next page.)
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Figure 4 Met-induced Pea3 propagation can be executed through PI3K and Src pathways. (A) ISH analysis of the establishment of Pea3
expression domain in spinal MNs . Images show brachial region of flat-mounted E12.5 spinal cords hybridised with Pea3 probes in WT, metd/d,
met2P/2P, and met2S/2S embryos. Whereas Pea3 MN pool is reduced in metd/d, it appears normal in met2P/2P and met2S/2S embryos. (B) Quantifications
of the lateral expansion of the Pea3 domain by signal intensity analysis: each plot represents the average signal distribution measured on the indicated
number of spinal cord sides along the red dotted line as positioned in each image in (A) (WT: n=14; metd/d: n=12; met2P/2P: n=6; met2S/2S: n=6).
(C): Brachial regions of flat mounted spinal cords stained with X-Gal to reveal β-galactosidase activity of the Pea3LacZ knock-in. This context
with only one functional copy of Pea3 is sufficient for complete Pea3 propagation by Met2P, but is not permissive for Met2S receptor. There was
a lack of propagation in metd/d: Pea3LacZ/+ as compared to met+/+:Pea3LacZ/+ spinal cords. (D) Quantifications of the lateral expansion of
the Pea3/β-galactosidase-positive domain by signal intensity analysis: each plot represents the average signal distribution as measured on
the indicated number of spinal cord sides (WT: n=8; metd/d: n=6; met2P/2P: n=8; met2S/2S: n=8) along the red dotted line as positioned in
each image in (C). (E,F) Quantifications and statistical analyses of the sum of the signal intensities corresponding to measurements of
Pea3 ISH in a Pea3+/+ context (B), or for X-gal staining in a Pea3LacZ context (D). Each dot represents the sum of intensity for one sample,
the number of samples being as indicated in (B) and (D). The absence of one Pea3 functional copy in a Pea3LacZ context reveals a significant difference
in Pea3 dosage requirement between met2P/2P and met2S/2S embryos.
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equivalent capacity to induce Pea3 propagation. To dis-
criminate between activation of selective pathways versus
background levels of shared downstream effectors, we
asked whether the signalling mechanisms in met2P/2P and
met2S/2S embryos could be genetically distinguished. We
reasoned that a way to address this issue was provided by
the fact that the process of expansion of Pea3 expression
involves a positive reinforcement loop during which met
and Pea3 are necessary for each other’s expression (see
Additional file 3: Figure S3) [16]. Indeed, we have shown
that Pea3 itself contributes to its own propagation, since it
is necessary to induce Met expression within the pioneer
domain, as shown in Pea3-/- mutants [16]. Consistently in
met loss-of-function mutants, the reduced expansion of
the Pea3 domain also results in reduced met expression,
as assessed by comparing β-galactosidase activity in
metLacZ/+ and metLacZ/d embryos (Additional file 1: Figure
S1D,G), whereas expansion of metLacZ expression was fully
executed in metLacZ/2P and metLacZ/2S embryos, paral-
leling the intact expansion of Pea3 expression domain
(Additional file 1: Figure S1D,G). We therefore challenged
the robustness of the MN pool specification function me-
diated by the Met signalling-switch mutants, by genetically
lowering Pea3 expression levels. We took advantage of the
Pea3LacZ knockout allele, in which the insertion of the
LacZ gene not only results in loss of Pea3 functions, but
also recapitulates the Pea3 expression domain [32]. Intri-
guingly, we found that whereas met2P/2P; Pea3LacZ/+ had a
pattern of β-galactosidase activity similar to Pea3LacZ/+
control E12.5 brachial spinal cords, met2S/2S; Pea3LacZ/+
displayed a significantly reduced number of blue MNs,
resulting in a phenotype similar to that of metd/d; Pea3LacZ/+
mutants (Figure 4C,D,F). Thus although switching signalling
cascades activated by Met mutants leads to comparable
efficacy to expand the Pea3 expression domain in the con-
text of two functional copies of Pea3, the signalling routes
employed by the Met signalling variants are differentially
sensitive to Pea3 gene dosage reduction: the Met2Sroute is sensitive, whereas the Met2P is not. This indi-
cates that higher Pea3 levels are required for its own
propagation of expression when mediated through a
Met2S/Src-dependent mechanism, whereas lower Pea3
doses are sufficient when propagation occurs via a Met2P/
PI3K-dependent cascade. Thus, the program for acquisi-
tion of Pea3 identity triggered by HGF/Met allows a
certain degree of signalling flexibility, and the competence
of alternative pathways to execute this function is differen-
tially dependent on the genetic dosage of Pea3.
Plasticity of Met signalling requirement for a cell
autonomous survival response in primary motor neuron
cultures
We next explored the plasticity of the MN survival sup-
porting function of HGF/Met when challenged with sig-
nalling switches. HGF is known to promote the survival
of subsets of limb-level MNs in culture [4,18,19]. In vivo,
the HGF/Met requirement for MN survival is limited to
lumbar MNs in chicks [33] and to a selective pool of
brachial MNs innervating the pectoralis minor muscle in
mice, as shown with neural-specific ablation of Met [4],
prompting us to focus our studies on this MN pool.
Studying the dependency on HGF/Met for MN survival
requires distinguishing its direct trophic function from the
indirect consequences of the trophic factors for depletion
resulting from myoblast migration defects. Bypassing the
consequences of decreased muscle mass in the limbs of
met-signalling mutant embryos can be achieved in vitro
using primary MN cultures and in vivo through neuronal
lineage-restricted signalling modulation of Met properties.
As a first approach, we assayed survival in primary
MN cultures established as described [34] from WT or
met-signalling mutant embryos at E12.5, a stage when
MN numbers were not affected yet by reduced muscle
mass (see Figure 3 and Additional file 1: Figure S1B).
E12.5 primary MNs were collected and pooled from
brachial and lumbar spinal cords, and then cultured in the
presence of either GDNF (100 pg/ml) or HGF (0.4 ng/ml
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MNs, both factors prevented the death of a proportion of
WT limb innervating MNs (Figure 5A,B: WT) [4,19,35].
Since MNs derived from metd/d, met2P/2P, and met2S/2S
embryos retained their ability to respond to GDNF
(Figure 5A) and to BDNF (data not shown), the response
to HGF was expressed as a percentage of GDNF-induced
survival, offering the possibility to normalise all experi-
ments performed. While metd/d MNs no longer responded
to HGF, MNs derived from met2P/2P and met2S/2S mutants
exhibited a survival response to HGF similar to that of
WT embryos (Figure 5B). As reported for the rat, WT
thoracic and sacral MNs required a higher concentration
of HGF (10 ng/ml) to survive [19]. We found that MNs
purified from thoracic and sacral regions (non-limb-in-
nervating MNs) from met2P/2P and met2S/2S but not from
metd/d embryos survived in response to HGF treatment
(data not shown). Since at the stage at which MNs are
collected for these primary cultures (E12.5) most Met-
expressing MNs are equally present in all genotypes,
(Figure 3 and Additional file 1: Figure S1), the ab-
sence of a survival response by metd/d mutant MNs is not a
consequence of a complete depletion of met-positive neu-
rons, but indicates that the Metd receptor does not trans-
duce survival signals. In contrast, cultures from met2P/2P
and met2S/2S spinal cords started with an unaltered
Met-responsive population compared to WTs (Figure 3,
Additional file 1: Figure S1, Additional file 5: Figure S5).
As their survival in response to HGF was comparable to
survival of WT MNs, this indicates that the Met2P and
Met2S receptors mediate the survival induced by HGF as
efficiently as the WT receptor. Altogether, these results
establish that signalling routes solicited by MetWT, Met2P
or Met2S are equally capable of triggering in vitro MN
survival by HGF.
The ability of the Met2P receptor to mediate a survival
response to HGF can be understood as the recruitment
and activation of the PI3K-Akt pathway, which is well
known to be involved in the inhibition of apoptosis [36].
In contrast, the survival function triggered by Met2S sug-
gests a novel link between Src and a survival pathway in
MNs. We therefore asked whether activation of Src me-
diated the survival response either by converging onto
the PI3K-Akt pathway (as reported for GDNF-induced
neuronal survival [10]), or by acting through an inde-
pendent mechanism. This question was addressed by
pharmacologically inhibiting the PI3K pathway or the
Src family kinases with the selective inhibitors LY294002
or PP2, respectively, at concentrations that do not
present toxic effects on the basal survival (LY294002:
1 μM; PP2: 0.2 μM; data not shown). We found that the
survival responses mediated by Met2P or by Met2S were
selectively abolished by LY294002 and by PP2, respectively
(Figure 5D), but not by PP3, a non-functional analogue ofPP2 (data not shown). These findings argue that the MN
survival response triggered by Met2P or Met2S specificity-
switch mutants are indeed mediated by PI3K or Src,
respectively, as they were designed to do [9]. Using PP2
and LY294002, we further showed that signalling by Met2P
does not require Src activity for survival, whereas the
survival response elicited by Met2S does not require PI3K
activity (Figure 5D). Interestingly, pharmacological inhib-
ition of Mek by PD98059 prevented the survival response
elicited by Met2S, but not by Met2P (Figure 5D). Together,
these experiments indicate that the MN survival promoted
by these specificity-switch receptors occurs through acti-
vation of distinct sets of signalling pathways. The survival
response triggered by Met2P in MNs is mediated through
an efficient activation of PI3K, and required neither Src
family kinases nor the Mek pathway. In contrast, the
mechanism by which Met2S mediates the survival re-
sponse does not involve the traditional PI3K-Akt survival
pathway, but rather activation of both Src family kinases
and the Mek pathway. Intriguingly, we found that all three
inhibitors abolished the survival response to HGF by WT
Met in MNs (Figure 5D). This indicates that unlike the
mutant receptors, for which altered docking sites have
forced the choice of one respective signalling pathway, in
a WT context, Met uses a combination of these three
signalling pathways. Altogether, the combination of our
genetic and pharmacological approaches indicates that
in vitro there is a remarkable plasticity in the signalling
requirements for MNs survival, which can be achieved
equally efficiently by alternative pathways permissive for
promoting survival (Figure 5E).
Plasticity of signalling effectors for Met-dependent motor
neuron survival in vivo
We next sought to determine whether such flexibility in
signalling requirements for HGF/Met-dependent MN
survival also occurs in vivo. In contrast to early stages,
once MNs have become dependent on muscle-derived
signals for survival, depletion of limb muscles in met-sig-
nalling mutants causes limb MN death [16]. This is illus-
trated by the disappearance of Pea3-expressing neurons
(Figure 6A) and the drastic reduction in the number
of Ret-expressing MNs occurring in metd/d embryos
at E14.5 (Figure 6B), as well as by the proportional
reductions of Pea3-expressing or Ret-expressing MNs
in the brachial spinal cord of met2P/2P and met2S/2S,
met2Pneo/2Pneo and met2Sneo/2Sneo embryos with reduced
volumes of muscles (Figure 6, Additional file 1: Figure
S1A, and Additional file 4: Figure S4A,D,E). Therefore,
the process of MN death that matches the number of
MNs with the number of myofibres in the cognate target
muscle, occurs between E12.5 and E14.5. This constitutes
genetic dating of the onset of muscle dependency, consist-
ent with previous observations [4,16].
Figure 5 Cell autonomous regulation of MN survival by Met can be achieved through distinct signalling pathways. (A) In vitro
assessment of survival of MNs derived from WT, met2P/2P, met2S/2S, and metd/d E12.5 embryos in the presence of GDNF (100 pg/ml). Survival values
are expressed as percentage of the survival in basal medium (defined as 100%). The ability of MNs to respond to GDNF is not altered in metd/d,
met2P/2P, and met2S/2S mutants. Therefore, in subsequent panels, values are normalised with the survival in basal medium (defined as 0%) and
expressed as percentage of their response to GDNF (defined as 100%). (B,C) Survival of brachial + lumbar (B) or thoracic (C) MNs derived from
WT, met2P/2P, met2S/2S, and metd/d E12.5 embryos in the presence of HGF (2 ng/ml). Whereas metd/d MNs do not show any survival response to
HGF, met2P/2P and met2S/2S MNs respond as efficiently as WT MNs. (D) Signalling requirements downstream of MetWT, Met2P, and Met2S for MN
survival by HGF were explored using inhibitors of PI3K (LY294002: 1 μM), Mek (PD98059: 1 μM), and Src (PP2: 0.2 μM), respectively). Inhibitors were
used at concentrations not toxic on the basal survival. All three inhibitors efficiently blocked the survival response of WT MNs to HGF. As
expected, the survival response in met2P/2P MNs was selectively blocked by the PI3K inhibitor. In contrast, the survival response in met2S/2S MNs
was abolished by inhibiting Src or Mek. For each genotype, two to four independent experiments were done in triplicate comparing MNs from
mutant embryos and from their WT littermates. (WT: n=9; , met2P/2P: n=3; met2S/2S: n=4; metd/d: n=2). Error bars indicate standard error of the
mean. (E) Schematic representation of the signalling components involved in blocking apoptosis downstream of the wild-type MetWT or the
specificity switch mutants Met2P and Met2S receptors. The inhibitors used are indicated.
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Figure 6 Conditional neuronal-specificity-switch of Met signalling to PI3K and Src is sufficient for pectoralis minor motor pool survival
in vivo. (A,B) Correlation between MN numbers in spinal cords with the amount of limb muscle in Met signalling mutants (see Figure 2A,B).
Analysis of MN pool survival in vivo after the onset of muscle dependency by Pea3 (A) or Ret (B) ISH on spinal cords from E15.5 WT, metd/d,
met2P/2P, and met2S/2S embryos (n = 3 spinal cords for each probe and each genotype). Limb muscle depletion in metd/d embryos causes the
death of all limb-innervating MNs, hence the complete loss of Pea3+ neurons and Ret-positive LMC but not axial columns. (C,D) Analysis of MN
survival in Nestin-Cre (referred to as Nes) mediated neuronal-specificity-switch mutants, which display unaltered amounts of muscle. (C) High
magnification views of ChAt ISH staining of the ventral horn of spinal cord cross-sections in Nes-Metflox/+, Nes-Metd/flox, Nes-Met2P/flox, and Nes-Met2S/flox
neonates (P2; n = 6 for each group of animals) at C8-T1 level. In this region, MN clusters are organized in two groups (dashed lines). The more ventral
cluster (red dashed lines) exhibits less MNs in the Nes-Metd/flox mutant, in contrast to Nes-Met2P/flox and Nes-Met 2S/flox mutants, which are comparable to
controls. (D) Quantification of MN numbers throughout the brachial region of Nes-Met d/flox, Nes-Met 2P/flox, and Nes-Met 2S/flox P2 mutants, showing
percentages of MN loss per section. Positions of the C8, T1, and T2 DRGs are indicated by black lines. In the C8-T1 region, where percentages of MNs
loss in Nes-Met d/flox mutants are highest, Nes-Met 2P/flox and Nes-Met 2S/flox mutants show non-significant MN loss, and are significantly different from
Nes-metd/flox mutants. Student’s t test: *P < 0.05, **P < 0.01, ***P < 0.001. Error bars represent standard error of the mean.
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owing to Cre-mediated excision in the nervous system
(Nestin-Cre) to demonstrate the direct control by HGF/
Met of the in vivo survival of a MN pool in the C8-T1
region corresponding to the pectoralis minor muscle [4].
As complete Nestin-Cre-mediated Met ablation occurred
only after the onset of NOCD, this strategy allowed us
not only to preserve muscle development, hence main-
taining an unaltered amount of muscle in the limb, but
also to bypass the early function of Met in the speci-
fication of the Pea3 pools and in motor nerve growth
(Figure 6C,D) [4]. This genetic paradigm also allowed us
to directly assess the net effect on MN survival attributed
to Met-signalling changes in MNs in vivo. We therefore
generated neuronal-specific-switch mutants in which one
allele of met is floxed by loxP sites and the other allele
carries the met signalling mutation: Nestin-Cre; metd/flox,
Nestin-Cre; met2P/flox and Nestin-Cre; met2S/flox (referred
to as Nes-Metd/flox, Nes-Met2P/flox and Nes-Met2S/flox,
respectively). In contrast to Nes-Metd/flox mutants, the
numbers of MNs measured in the Nes-Met2P/flox and Nes-
Met2S/flox mutants were equivalent to WT, with only minor
non-significant reductions at T1 level (Figure 6C,D,
Additional file 6: Figure S6). Thus, survival of the pector-
alis minor MN pool is not compromised in neural-
specificity-switch Met mutants, as was found in our
culture assays. Altogether, these results show that signal-
ling routes downstream of the Met RTK can substitute for
each other to promote MN survival and that those soli-
cited by Met2P and Met2S are equivalent in their efficacy
in accomplishing this task. Such findings illustrate the
remarkable degree of plasticity of Met signalling cascades
ensuring survival, in contrast to the strict specificity
required for Met-dependent axon guidance and to the
partial flexibility for Pea3 identity acquisition by the HGF/
Met system.
Discussion
Signalling pathways are solicited to convey information
from membrane receptors activated by growth factorsto coordinate a set of outcomes including short-term
transcription-independent responses and long-term gene-
expression changes. When the same receptor is employed
to trigger distinct biological responses in a given cell type,
each response can be achieved through the activation of
distinct signalling cascades. The degree to which a given
signalling cascade is uniquely required for a specific
biological response, or can be substituted by an alternative
pathway, depends on the cell type, the nature of the
response, the strength of the signal and the robustness of
the signalling network available for this biological out-
come. We have investigated this issue in vivo in the con-
text of several biological requirements of the HGF/Met
system in MNs, using a set of mouse lines carrying signal-
ling mutations of Met that modulate the phosphotyrosine
binding preferences, and thereby limit the range of signal-
ling effectors mobilised by the modified receptor. We
showed that in MNs, alternative HGF-induced Met cas-
cades such as the PI3K or Src/Mek pathways, although
biochemically or genetically distinguishable, are inter-
changeable to ensure MN survival, and MN specification,
but not for axon guidance (Figure 7).
Degree of equivalence of signalling cascades and
robustness of a biological response
A growing set of data supports the idea that signalling
effectors are in charge of selective biological responses
following RTK stimulation. While the view 15 years ago
conveyed the idea that a given signalling cascade would
be uniquely required for a given response, it has now
emerged that several alternative pathways, although dis-
tinct from each other by their components, can substitute
for one another to activate a given biological response.
Therefore, the robustness of a biological outcome corre-
lates with the capacity of cells not only to buffer variations
of signal intensities [37], but also to offer a multiplicity
of signalling molecules that can efficiently replace each
other to ensure a given response [38,39]. Here we asked
to which extent several biological responses to one pleio-
tropic RTK, Met, are compatible with substitutions of
Figure 7 Summary of the signaling modalities characterizing each of the functions of HGF/Met in MNs. (A,B) Schematic summary of
the MN populations in which HGF exerts its functions, highlighting which subsets express Met. (A) Scheme representing the three subsets of
Pea3-expressing MNs, and the mechanism by which GDNF and HGF cooperate to establish Pea3 expression domain, based on [16]: GDNF acts on
Ret/GFRa1 expressing “pioneer” neurons (dark blue pool, believed to largely match the CM MN pool in general) , to induce Pea3 expression. Pea3
in turn is required to induce expression of the HGF receptor Met. HGF acts on the same “pioneer” neurons, once they express Met, to trigger the
production by these neurons of a signal (referred to as X) that induces Pea3 expression in additional neurons (“recruited”). This leads to the lateral
enlargement of the CM pool (within which Met expression propagates as well), and to the recruitment of more anterior neurons (red, largely
matching the LD MN pool), which will not express Met. (B) Scheme representing lumbar axonal MN projections in the hindlimb, with colours
distinguishing Met-dependent from Met-independent guidance. (C) Summary table of the various biological aspects of neuromuscular development
involving HGF/Met. Columns distinguish the nature of the biological response (cell fate specification, axon growth/guidance, and survival); rows
distinguish the MN populations, matching them to their position in the schemes in (A, top) and (B, bottom). The table indicates for each
response/MN population the respective degree of muscle dependency, the corresponding function of HGF/Met, whether it is cell autonomous or
not, and the degree of execution by signalling solicited by Met2P and Met2S specificity-switch mutants (with green indicating complete execution, and
red indicating abrogation).
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faithful execution:
(a) Substitutable pathways, considered permissive for a
given biological response, induce a cascade of
biochemical events that converge towards and
mobilise key activator(s) of this response,
compatible with a positive outcome. Considered
together, all components of alternative/substitutable
pathways capable of mediating a given response can
constitute an equivalence group, where the lack of
one component (or lowered signalling levels by one
component) can easily be compensated for by the
network of available relationships between the
others [39-41]. This concept has been instrumentalin understanding pathways leading to cancer, where
mutations in any component of a given equivalence
group (also called a core pathway) are mutually
exclusive and tend not to co-occur in the same
tumour [41,42].
(b) Conversely, a pathway is considered non-permissive
when it is not substitutable with another one, and
when activation of an alternative pathway will not
lead to the same output (even leading in some cases
to the opposite outputs, for example attraction
versus repulsion in axon guidance).
Whether certain pathways are equivalent (permissive)
or not depends, on one hand, on the cell type (whether
it is competent to offer a robust plasticity network to
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nature of the biological outcome. Our results distinguish
three types of biological outcomes, which are discussed
in the following paragraphs:
Non-equivalence of signalling cascades for axon
branching towards muscle targets
We showed that switching Met binding preferences to-
wards Src family kinases precludes axonal branching to
target muscles by HGF/Met, while accommodating PI3K
recruitment ensures correct peroneal nerve patterning in
the hindlimb (Figure 7). These differences of biological
competences between Met2P and Met2S, with respect to
axonal growth and intramuscular branching, are import-
ant for two main reasons:
(1) They allow unambiguous uncoupling of Met
requirements for axonal growth from muscle
development, and they also allow distinguishing of a
nerve pattern defect from the consequences of an
altered MN specification process (unlike for brachial
Pea3 MN pools). The amount of muscle mass
present in the limbs due to limited myoblast
migration varies from embryo to embryo, although
to a similar extent in met2P/2P and met2S/2S embryos
(Figure 2C,D). Cases with no muscles (where the
TA muscle is completely missing) result in the
absence of nerve branches exiting the main peroneal
nerve, even in a small subset of met2P/2P embryos.
This reflects the fact that muscles are necessary for
sending a branching signal. However, in the
presence of equivalent amounts of muscle mass,
such branches are unequivocally detected in met2P/2P
but not in met2S/2S embryos, where the nerve pattern
is indistinguishable from that seen in metd/d mutants.
This indicates that Met signalling is essential for the
decision of motor axons to exit the main nerve and
enter the muscle, provided that the competent
signalling effectors are mobilised. According to these
results, the muscle-derived signal may be either HGF
itself or a protein necessary for HGF to bind/activate
its receptor, such as enzymes involved in HGF
precursor cleavage and/or in its extracellular
diffusion [43-45].
(2) The complete inability of the Met2S receptor to
execute an axonal branching decision, which
contrasts with its capability to trigger MN survival,
indicates that Src family kinase activation is
inadequate for axonal branching by HGF/Met
(or that Src antagonises the response otherwise
mediated through another pathway such as PI3K;
see below). These results apparently contrast with
other ligand/receptor systems in which Src family
kinases have been reported to be required for axonguidance but not for survival of MNs [46]. In this
study, interfering with Src signalling in developing
chicken spinal cords resulted in axonal path-finding
errors at the dorsoventral choice point in the limb
[46], a decision cooperatively controlled by
ephrinA/EphA and GDNF/Ret signalling pathways
[16,47-49]. Similarly, inactivation of the Drosophila
Src homologue causes aberrant midline crossing
indicating that Src is required to inhibit crossing
of longitudinal axons [50]. A possible explanation
for this apparent discrepancy with our results
may be that Src family kinases are involved in
non-permissive pathways, where they instruct axons
of the behaviour they should adopt (whether they
should be attracted or repelled) in response to
various signalling cues. Consistently with this
hypothesis, Src family kinases are involved in
repulsive responses downstream of ephrin reverse
signalling [51,52], but mediate attractive turning
responses to Netrin [53]. Thus, for the HGF/Met
system, Src activation by Met2S may have turned an
attractive/positive response into a negative/repulsive
one, for example by mobilising a cascade normally
involved in a negative response to another signal. In
such a context, Src activation would therefore not
be dispensable, but rather would antagonise the
normal function of Met. In contrast, the PI3K
pathway appears as a permissive pathway, which
may serve as a switch to activate responsiveness or
as a rheostat to modulate the intensity of a unique
one-sided response of axonal growth [54]. What
determines whether Src family kinases will mediate
an attractive or repulsive response may be encoded
by intrinsic differences between neuron subtypes,
for example through differential expression of
receptor complexes or signalling effectors involved
in gating the nature of this decision [55-57]. An
alternative possibility could be that in the WT
context, Src family kinase recruitment by Met
occurs only in a MN subtype-specific manner; for
example Src may not be solicited in those MNs in
which Met regulates guidance (CM, peroneal axons).
In this context, modifications of the Met binding
preference may result in an ectopic Src family kinase
activation, thereby removing the pool-specificity and
silencing the response of neurons.
Two non-equivalent pathways can substitute for each
other to control cell fate acquisition
In contrast to the clear incapacity of signalling by the
Met2S receptor to execute axon guidance decisions, the
cascade of events allowing expansion of the Pea3 expres-
sion domain in the brachial motor columns is efficiently
executed by both Met2P and Met2S receptors, the two
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gene dosage (Figure 7). Pea3 expression was previously
shown to be initially activated by GDNF in a subset of
brachial MNs [31]. We have previously added another
degree of complexity by showing that this induction was
restricted to a pioneer group of Met-expressing neurons,
in which Met is required to trigger the production of a
signal propagating Pea3 expression to anterior neurons
(Figure 7A, Additional file 3: Figure S3 and [16]). With
known inducers of Pea3, such as FGF8/3 and Wnt1, not
being expressed in the pioneer pool, work is currently
underway to identify the signal, induced by HGF/Met in
pioneer neurons, that is responsible for expansion of the
Pea3 expression domain, not only laterally, within the
Met-expressing CM MN pool, but also to Met-negative
anterior MNs. The results of the present study indicate
that the signalling cascades mobilised by both Met2P and
Met2S receptors equivalently allow triggering of the
production by pioneer neurons of this signal mediating
expansion of Pea3 expression to recruited neurons. The
sensitivity to lowered Pea3 levels in the Met2S scenario
indicates that the responsible signalling cascade involves
Pea3 transcriptional activity. This further implies that
this Pea3-inducing signal must be a Pea3 target gene.
The possibility that Pea3 could be involved in its own
propagation is consistent with the reduced domain of
Pea3-lacZ expression described for Pea3-null embryos
[32] and with the fact that Met expression in the pioneer
domain is regulated by Pea3 (Additional file 1: Figure S1)
[16]. The differential effectiveness of the signalling cascade
activated by the Met2P and Met2S receptors suggests that
Pea3 transcriptional activity might be regulated by Src but
not by PI3K. Pea3-family transcription factors are typically
known to be activated by a Ras-Mek axis downstream of
FGF signalling [58-62]. A recent study shows that ERK
signalling mediates induction of Etv4 (pea3) and Etv5
expression in sensory neurons by target-derived neuro-
trophic factors such as NGF [63]. Our own result from
MN survival assays suggest that the pathway mobilised by
the Met2S receptor for survival also involved the ERK
pathway through Mek activation. It is therefore tempting
to speculate the existence of a Src-Mek-Pea3 circuit
available downstream of HGF/Met in MNs. Consistent
with this hypothesis, Pea3 was shown to be involved
downstream of v-src signalling to activate transcription of
collagenase 1/MMP1 [64].
Moreover, Pea3 loss-of-function disrupts Src activation
and cell mobility in Pea3-null fibroblasts, indicating that
Src can also be activated and required downstream of
Pea3 [65]. Such a reciprocal relationship between Pea3
and Src could explain why a twofold lowering of Pea3
expression does not impair propagation of Pea3 expres-
sion in a WT Met signalling context, but becomes crit-
ical in the context of a signalling-switch mutant of Metpredominantly relying on Src activation. In contrast, the
fact that signalling by the Met2P receptor is not sensitive
to reduced Pea3 dosage indicates that production of the
signal mediation expansion of Pea3 expression can also
be induced by other transcription factor(s). Thus, the ro-
bustness of the cell fate specification function triggered
by the Met RTK relies on a complex signalling circuit
possibly composed of a combination of distinct tran-
scription factors, the activity of which is modulated
qualitatively and/or quantitatively by upstream signalling
cascades.
Equivalence of signalling cascades for neuronal survival
Finally, we found that signalling pathways mobilised by
either the Met2P or Met2S receptors were equally capable
of substituting for the WT pathways in regulating MN
survival. This is supported by primary MN culture
experiments and by in vivo studies on Met-dependent
pectoralis minor MN pool survival [4] using neuronal-
specificity-switch Met mutants. In vitro, survival by HGF
in met2P/2P MNs is selectively mediated by PI3K, but not
by Src or Mek, whereas in met2S/2S MNs, survival re-
quires Src and Mek, but not PI3K. Neuronal survival by
numerous neurotrophic factors, including HGF in MNs
[35], involves the traditional PI3K-Akt pathway. Akt
regulates components of the apoptotic machinery, such
as Bad, a pro-apoptotic member of the Bcl-2 family, and
Forkhead box transcription factors, which are involved
in expression of other death genes [66,67]. Besides this
main road, alternative pathways can also be employed
for cell survival [68]. For example, a number of studies
have provided evidence that Src is required for survival
promoted by GDNF, by cytokines, such as CNTF, or by
the P2Y2 receptor, in cultured embryonic MNs or osteo-
clasts. Nevertheless, in these cell types Src survival prop-
erties are still dependent on the PI3K-Akt pathway
[10,35,69-71]. The requirement of Src and Mek, but not
PI3K, for MN survival by Met2S implies either a parallel
action of Src and Mek-ERKs pathways, or the existence
of a circuit involving activation of Mek-ERKs by Src. A
previous report on chick MNs has indicated that Mek
signalling is dispensable for their survival [36]. However,
saturating concentrations of HGF (10 ng/ml) were used
in this study, whereas we favoured assessing the signal-
ling required for survival using HGF doses more similar
to the physiological context (0.4 ng/ml or 2 ng/ml). It is
possible that with saturating amounts of ligand, path-
ways such as PI3K are over-activated to an extent that is
sufficient for MN survival, even in the absent of other
signalling components such as Mek. In contrast, with
the lower concentration of HGF that we used (closer to
the levels occurring in vivo), the level of activation of
each individual pathway may not be sufficient to pro-
mote survival independently of the others. This scenario
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have evidenced in vivo, in the context of our neuronal-
restricted Met specificity-switch mutants.
Intriguingly, the signalling pathways initiated by Met2P
and Met2S receptors are adequate for survival of MNs,
but not of embryonic hepatocytes both in vitro and
in vivo [23-25]. Such a paradox illustrates the extent to
which the signalling efficacy for a given biological re-
sponse is influenced by the cell type. This may be related
to intrinsic factors, such as the biological state of
cells (e.g. proliferating versus quiescent), or to extrinsic
factors, such as extracellular levels of stress signals. An-
other reason may be differences in expression patterns
and levels of signalling components in embryonic MNs
versus hepatocytes. In this respect, Additional file 7:
Figure S7 offers an illustration of the expression patterns
of several members of various signalling families, based on
the GenePaint database [72]. It is interesting to note that
several adaptors expressed at high levels in the nervous
system, some of them even specifically in brachial MN
pools, appear either not to be expressed in the liver or to
be expressed at much lower levels.
The high plasticity of signalling networks controlling
MN survival is particularly intriguing, when taking into
account the unexpected discovery that PI3K, Src and
Mek-ERK pathways are all necessary downstream of the
WT Met receptor, each of them being, however, insuffi-
cient on its own to provide a robust survival response in
the absence of the other pathways in vitro. This con-
trasts with the fact that Src is dispensable downstream
of Met2P and PI3K is dispensable downstream of Met2S.
A possible explanation of this apparent discrepancy could
be that in MNs, Met specificity-switch receptors behave as
mild gain-of-function mutants for some pathways, while
being incapable of activating the others. This increased
level of activation of individual signalling routes down-
stream of Met2P or Met2S would raise their activity above
a threshold necessary to activate effectors of survival,
whereas this threshold is only reached by the combined
activity of PI3K, Src and MAPK pathways downstream of
WT Met. According to this scenario, such increased levels
above the threshold could alleviate the simultaneous
requirement for the other pathways to induce a survival
response successfully in MNs. As mentioned above, this
contrasts with hepatocytes, in which signalling initiated by
Met2P or Met2S receptors is insufficient to ensure a
survival response to HGF [23-25], thus indicating that the
gain-of-function character is conditioned by the compe-
tence of the cell type. Molecular analysis of signalling
circuits downstream of Met WT and Met mutants would
offer the possibility of uncovering the components and
levels of their activation that ensure the robustness of
survival circuits in MNs. However, addressing this ques-
tion would require detailed molecular and biochemicalanalyses that are technically not compatible with the
number of MNs accessible from embryos, and would be
challenged by the switch in biological responses and in
MN subtypes occurring throughout development.
Conclusions
How can we interpret the specificity of signalling path-
ways necessary for axonal growth compared to the plas-
ticity allowed when executing RTK-induced MN survival
or specification responses? Axon guidance is a complex
example of a biological response regulated by several
non-equivalent signalling components. Their activation
leads to choices between multiple qualitatively different
outcomes, such as stop, go, turn, exit, etc., thereby
requiring intercalation of multiple signalling systems to
gate the decision-making process at the level of the
growth cone. Such a context implies that some signalling
cascades need to be specifically associated with selective
outcomes rather than being permissive, for the proper
integration of multiple instructive axon guidance signals.
In contrast, MN survival and specification are dichoto-
mic choices at the cell level, integration of which at the
tissue level involves the quantitative assessment of indi-
vidual neuron responses to the limited amount of neuro-
trophic factors produced by target tissues. Adaptation of
the MN numbers in each pool to the size of its cognate
muscle target is achieved by a mechanism capable of
measuring accurately the amount of target-derived signal
available, and of adjusting this amount with respect to
an intrinsic threshold within each cell, to block the
apoptotic cascade or to activate the specification program.
Likewise, raising RTK signalling levels above endogenous
thresholds can enhance the neuroprotective effect and
limit susceptibility to MN diseases [73]. The plasticity
allowing several alternative pathways to substitute for each
other to achieve such responses confers robustness to the
mechanisms coordinating the development and size of the
neuromuscular system.
Methods
Animals and genotype analysis
The generation of the different signalling alleles of the
met gene used in this study (metd, met2P and met2S) has
been described previously [9,15]. The original neo+ al-
leles, which contained a neo selection cassette flanked
by LoxP sites, were referred to as met2Pneo and met2Sneo.
Alleles without neo were obtained after excision of the neo
cassette by crossing mutant mice with the Deleter-Cre
transgenics [9]. Genotype analysis by PCR was performed
as described [9,12]. The metLacZ allele is an alternative
knockout/knock-in allele of met in which the LacZ
reporter gene also reflects expression of the endogenous
met gene [4]. In the original allele, LacZ expression is con-
ditioned by the removal of a Lox-stop-Lox cassette [4]. In
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have derived a mouse line in which the stop cassette
has been permanently deleted. Genotype analysis was
performed by PCR as described [4]. Pea3-lacZ mice
were used with the permission of Arber and Jessell, and
genotyped as previously described [32]. Animals were
maintained and sacrificed in accordance with institu-
tional guidelines. Adult mice were euthanised by cervical
dislocation.
In situ hybridisation
Embryos were collected in phosphate-buffered saline
(PBS) and fixed in 4% paraformaldehyde (PFA). ISHs
were performed with the relevant RNA probe on either
whole-mount embryos, dissected limbs or spinal cords,
according to previously published procedures [16].
Whole spinal cord ISH was performed as described [74],
with digoxigenin-labelled RNA probes for met, MyoD
(obtained from Ponzetto), Pea3, (from Jessell), Ret (from
Rosenthal) and ChAT (choline acetyl transferase; from
Henderson). Spinal cords were flat mounted as open-book
preparations with MNs on the upper side, and imaged
using a Zeiss Axiophot (Marly le Roi, France) or Leica
stereomicroscope (Wetzlar, Germany). Whole-mount em-
bryos were partially cleared in 50% glycerol and imaged
using a stereomicroscope.
X-Gal and Salmon-Gal staining for β-galactosidase activity
Staining for β-galactosidase activity was performed using
two alternative methods. For spinal cords of embryos
carrying the pea3LacZ allele, we employed the traditional
protocol using X-Gal substrate in combination with fer-
ric and ferrous ions. Briefly, spinal cords were dissected
from freshly collected embryos, fixed in 4% PFA in PBS
(40 min), rinsed in PBS, and incubated in X-Gal in com-
bination with potassium ferricyanide and ferrocyanide
(FeCN). To detect β-galactosidase in the spinal cords of
embryos carrying the metLacZ allele, we used an alternative
method based on Salmon-Gal (6-chloro-3-indolyl-beta-D-
galactopyranoside from Appolo scientific, Maschester, UK)
in combination with tetrazolium salt [75]. Briefly, spinal
cords were dissected from freshly collected embryos, fixed
in 1% PFA and 0.2% glutaraldehyde in PBS (10 min), rinsed
three times in PBS, then incubated for a minimum of 7 h
overnight at 37°C in pre-stain solution without substrate
(potassium ferricyanide 200 mM, potassium ferrocyanide
200 mM, 4 mM MgCl2 and 0.04% NP40 in PBS) to reduce
endogenous β-galactosidase activity. Samples were then
rinsed three times in PBS, and incubated in staining solu-
tion (1× PBS, with 0.04% NP40, 2 mM MgCl2, 1 mg/ml
Salmon-Gal (stock solution 40 mg/ml in dimethyl
sulfoxide (DMSO)) and 0.33 mg/ml NBT (stock solution
75 mg/ml in 70% DMF)), for about 30 to 40 min at 37°C.
In all cases (X-Gal and Salmon-Gal), staining wasterminated by rinsing in PBS, and post-fixing in 4% PFA.
Spinal cords were flat mounted in 1 volume glycerol/1
volume 4% PFA for imaging.
Embryonic motor neuron cultures
E12.5 mouse embryos were collected in Hibernate (E)
medium (Life Technology) with B-27 supplement (Life
Technology) and kept on ice until the dissection, while
the genotype was determined by PCR. Ventral spinal
cords from an equal number of WT and mutant embryos
were dissected. MNs were isolated from either brachial +
lumbar, or from cervical + thoracic + sacral segments, by a
previously described method [34] involving a combination
of centrifugation on BSA cushions and a metrizamide
density gradient centrifugation. At the end of the proced-
ure, the cell suspension was highly enriched in MNs.
For survival assays, MNs were plated in polyornithine/
laminine-coated four-well tissue culture dishes (1,500
neurons per well) in Neurobasal medium (Life Technology,
Saint Aubain 91190, France). Recombinant neurotrophic
factors and inhibitors were added 2 h after seeding. MNs
were kept for 3 days either in Neurobasal medium or
in the presence of GDNF or HGF (both obtained from
R&D, Minneapolis, MN, USA). All inhibitors (LY294002,
PD98059, PP2 and PP3) were obtained from Calbiochem
(Darmstadt, Germany). PP3 was used as a negative control
for PP2 (not shown). MN survival was quantified by
counting large bright unipolar neurons with long axonal
processes on the whole area of each well.
Whole-mount anti-neurofilament immunohistochemistry
Embryos were collected in cold PBS, fixed for 2 h in 4%
PFA in PBS, and post-fixed overnight in Dent’s fixative
(80% methanol, 20% DMSO) at 4°C. Whole-mount anti-
neurofilament immunohistochemistry was performed as
previously described [29]. Briefly, embryos were bleached
for 4 h in 6% H2O2 in Dent’s solution and further rehy-
drated through a progressive methanol series. Antibody
incubations were performed in 80% newborn calf serum,
20% DMSO, 0.5% triton with thimerosal. Antibodies used
were the following: anti-neurofilament antibody (2H3 and
DSHB) and HRP-conjugated goat anti-mouse antibody
(Sigma). Staining was developed using DAB Tablets (Sigma,
Saint-Quentin Fallavier, France). Embryos were cleared for
imaging in BABB (1:2, benzyl alcohol/benzyl benzoate).
Image processing and analyses
Quantification of signal intensity was performed using the
ImageJ software. Briefly, images of ISH were first con-
verted to a grey scale and inverted to a negative scale (with
the highest signal intensity matching being white and the
lowest black). Signal intensity was measured along a hori-
zontal line of a given pixel length (matching half a flat-
mounted spinal cord, always positioned where indicated
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threshold subtraction, the values were averaged between
several samples of each genotype (considering left and
right sides separately, for the number of spinal cord sides
used, for each plot indicated in the corresponding figures)
to generate an average signal distribution plot. The total
signal intensity was also calculated for each sample, and
plotted individually (Figures 2 and 5, Additional file 1:
Figure S1 and Additional file 4: Figure S4).
Statistical analysis
Results were expressed as mean ± standard error of the
mean. Statistically significant differences were assessed by
unpaired Student’s t-test when data were showing a
normal distribution, and by the Mann–Whitney test
otherwise. * indicates P < 0.05 and ** indicates P < 0.001.
Additional files
Additional file 1: Figure S1. Figure S1. Met-deficiency-triggered
reduced limb muscle volume does not cause MN loss at E12.5. (A)
Analysis of muscle migration by whole mount MyoD ISH on E11.5 (top
row) or E12.5 (bottom row) embryos, showing forelimbs Of WT and met
signalling mutants (n = 3 embryos per genotype and stage). (B) Ret ISH
in brachial spinal cords from E12.5 WT, metd/d, met2P/2P, met2S/2S embryos.
(C) The size of the Ret-expressing brachial MN pools was assessed using
measurements with Image J of Ret ISH staining intensity along the
orange dotted line at C7 level. Each plot represents the average signal
distribution of the indicated number of spinal cord sides (met+/+: n=18;
metd/d: n=14; met2P/2P: n=10; and met2S/2S: n=8). (D) Met expression was
followed by Salmon-Gal staining in spinal cords from E12.5 metLacZ/+;
metLacZ/d; metLacZ/2P; and metLacZ/2P embryos. Images show the brachial
region of the same spinal cords shown in Figure 3C. (E) Quantification of
the size of the Met-expressing brachial neurons along the orange line at
C7 level. Each plot represents the average signal distribution of the
indicated number of spinal cord sides (metLacZ/+: n=22; metLacZ/d: n=8;
metLacZ/2P: n=18; and metLacZ/2P: n=10). (F, G) Quantifications and
statistical analyses of the sum of signal intensity corresponding to
measurements of Ret ISH staining (F), or MetLacZ expression (G), based on
intensity plots in (C) or (E), respectively. Numbers of samples are as
indicated in (C) and (E). At E12.5, the size of the Ret-expressing MN
population is not significantly altered in met mutant embryos, as MN
numbers are independent of muscle mass at this stage. In contrast,
analysis of metLacZ expression confirms that met is required for its own
expression in the C7-C8 brachial pool, signalling via either PI3K or Src
being equally efficient to ensure establishment of met expression
domain.
Additional file 2: Figure S2. Altered peroneal nerve guidance in
absence of Met signalling cannot be attributed to lowered Pea3
expression. (A) Scheme of the lumbar spinal nerves and plexuses at
hindlimb levels (same as in Figure 3A) based on a lateral view of an E11.5
WT embryo, showing that the sacral plexus is located caudal to the
sciatic plexus, and collects axons mostly originating from L6 and S1
spinal segments. (B) Double ISH with Met (blue) and Pea3 (red) probes
(left), or with the Pea3 probe only (right), was performed for E12.5 WT
spinal cords to show their respective expression patterns in the lumbar
region in apposition with spinal segments and the corresponding
plexuses shown in (A). Overall a longitudinal column expressing Pea3 lies
more ventral (closer to the midline) than the Met-expressing motor
neurons at L4–5–6 levels, while the caudal part of the Pea3 domain maps
to the sacral segments, thus corresponding to projections to the sacral
plexus. Therefore, Pea3 is not expressed in Met-expressing peroneal motor
neurons (yellow dotted pools). (C) Analysis of Pea3 and its target geneSema3E expression in lumbar spinal cords of WT and metd/d embryos
confirms that, as previously shown for the brachial region, Met is also
required for expansion of expression of Pea3 and Sema3E in the lumbosacral
region (n = 4 spinal cords for each probe and each genotype).
(D) Anti-neurofilament (NF) immunohistochemistry for hindlimbs of
WT and Pea3LacZ/LacZ E12.5 embryos, showing that Pea3 functions are
dispensable for peroneal nerve guidance. (E) High magnification of
the area from a WT E13.5 hindlimb stained with anti-NF antibody,
where side branches exit the deep peroneal nerve to make contacts
with muscles. The right panel shows the same picture a white line
highlighting the nerve, and green lines highlighting side branches.
Additional file 3: Figure S3. Scheme representing the three subsets
of Pea3-expressing MNs, and the mechanism by which GDNF and HGF
cooperate to establish Pea3 expression domain, based on [16]: Step1:
prior to GDNF secretion by the plexus mesenchyme, Pea3 is not
expressed, but a subset of neurons express the receptor Ret/GFRa1
coupe. Step2: GDNF acts on Ret/GFRa1 expressing “pioneer” neurons
(dark blue pool, believed to largely match the CM MN pool), to induce
Pea3 expression. Pea3 in turn is required to induce expression of the HGF
receptor Met. Step3: HGF acts on the same “pioneer” neurons, once they
express Met, to trigger the production by these neurons of a signal
(referred to as X) that induces Pea3 expression in additional neurons
(“recruited”). This leads to the lateral enlargement of the CM pool (within
which Met expression propagates as well), and to the recruitment of
more anterior neurons (red, largely matching the LD MN pool), which will
not express Met. Expression of Pea3 in the Pec Min MN pool appears to
occur independent of GDNF [31], but which peripheral factor is required
for this induction has not been identified.
Additional file 4: Figure S4. MN survival is proportional to the amount
of muscle in developing limbs in embryos with attenuated expression
levels of Met-signalling variants. (A) Analysis of muscle migration by
whole-mount MyoD ISH in WT, met2Pn/2Pn and met2Sn/2Sn E12.5 embryos
at forelimb levels (n = 3 embryos for each genotype). Note that the
presence of a neo cassette in the met locus further reduces the ability
of mutant receptors to promote myoblast migration and colonisation of
the limb, due to attenuation of receptor expression levels. Consequently,
muscle masses in met2Pn/2Pn and met2Sn/2Sn embryos are reduced
compared to met2P/2P and met2S/2S embryos (see Additional file 1:
Figure S1A,B). (B–E) ISH was performed with Pea3 (B,D) and Ret (C,E)
RNA probes on spinal cords from E12.5 (B,C) and E14.5 (D,E) WT,
met2Pn/2Pn and met2Sn/2Sn embryos (with a minimum n = 3 spinal
cords for each probe, stage and genotype). Quantification of the lateral
expansion of the Pea3 domain (B) and assessment of MN numbers through
Ret ISH (C), were performed by measuring signal intensity; each plot
represents the average signal distribution measured on the indicated
number of spinal cord sides (WT n = 14 for Pea3 and n = 18 for Ret;
met2Pn/2Pn n = 6 for each probe; met2Sn/2Sn n = 6 for each probe), the two
sides being considered separately, along the red dotted line for each image.
Measurements were performed with ImageJ, after negative conversion
and background subtraction. This analysis shows that prior to muscle
dependency, overall MN numbers are unaffected by reduced muscle
mass and that the Met2P and Met2S receptors, in spite of reduced met
expression levels in met2Pn/2Pn and met2Sn/2Sn embryos, retain an intermediate
but comparable capacity to promote expansion of the Pea3 expression
domain (as quantified in (C), P > 0.89). (D,E) After the onset of muscle
dependency (at E14.5), as expected, the reduced MN survival in met2Pn/2Pn
and met2Sn/2Sn embryos correlates with reduced muscle masses. Again,
met2Pn/2Pn and met2Sn/2Sn embryos do not appear different from each other.
Additional file 5: Figure S5. Detection of Met-expressing MNs in the
brachial spinal cord of Met signalling mutants. Met expression was
detected in E13.0 spinal cords from WT, metd/d, met2P/2P and met2S/2S
embryos (minimum n = 3 spinal cords per genotype) by ISH with an RNA
probe matching the met extracellular domain, which was unchanged by
the genetic modifications to the met locus. The spinal cords (unopened)
are imaged from their left side, at the brachial level, with anterior to the
left and posterior to the right.
Additional file 6: Figure S6. MN numbers in neural-specific Met
signalling mutants. MN numbers were quantified at P2 in the brachial
region (C8-T1) of Nes-Met2P/flox (n = 8) (A) and Nes-Met 2S/flox (n = 7)
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MNs were quantified on cryosections shown in Figure 5C. Positions
of the C8, T1 and T2 DRGs are indicated by black lines. These graphs
correspond to the graphs shown in Figure 5D displaying percentage of loss.
Additional file 7: Figure S7. Potential for plasticity of signalling
pathways illustrated through expression patterns of signalling effectors.
Sagittal sections of E14.5 mouse embryos hybridised with the indicated
probe (expression data are extracted from the GenePaint database).
Brachial MN pools are indicated by arrows. (A) Src family kinases and
associated effectors. (B) PI3K subunits and downstream effectors (Akt1).
(C) MAPK family and effectors. When the indicated gene is expressed in
brachial MN pools, a magnification of the area is shown.
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